Showing 31-40 of 5304 results for "".
Journal Club: S. Aureus-Driven AD Exacerbation
https://practicaldermatology.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-s-aureus-driven-ad-exacerbation/32404/Practical Dermatology Editorial Board member Christopher Bunick, MD, FAAD, discusses a recent Journal of Drugs in Dermatology article about the need for a novel treatment for S. aureus exacerbated atopic dermatitis with Adelaide Hebert, MD.Schachner LA, Andriessen A, Gonzalez ME, Lal K, Hebert AA, EActive Vitiligo: What to Look For
https://practicaldermatology.com/series/updates-vitiligo/active-vitiligo-what-to-look-for/24156/John E. Harris, MD, founding director of the Autoimmune Therapeutics Institute at the University of Massachusetts Chan Medical School, talks with Practical Dermatology Chief Medical Editor Neal Bhatia, MD, about the clinical signs of active vitiligo.Do This Now: Be a Better Leader
https://practicaldermatology.com/topics/practice-management/do-this-now-be-a-better-leader/19111/Speaking at the Vegas Cosmetic Dermatology meeting, Todd E. Schlesinger, MD shares tips for becoming a better leader in your aesthetics practice--whether you own the practice or not. Understanding personalities and leading outside the practice walls are key.Vitiligo: Current and Future Developments
https://practicaldermatology.com/conferences/maui-derm-2020/vitiligo-current-and-future-developments/19722/John E. Harris, MD, PhD reviews treatment advances and emerging science in vitiligo. From new topical agents to intriguing studies on a potential role for biologics, there is very good reason to be optimistic about the future of vitiligo treatment.SCALE 2024: Dr. Hilary Baldwin on Benzyl Peroxide Best Practices
https://practicaldermatology.com/conferences/scale-2024/scale-2024-dr-hilary-baldwin-benzyl-peroxide-best-practices/26375/Hilary E. Baldwin, MD, provides and update on the recent issues surrounding benzyl peroxide, including a recommendation to dispose of any expired benzyl peroxide products and a discussion of proper storage, at Music City SCALE.Considerations for Treatment Downtime After Laser Therapy in Scar Repair
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/considerations-for-treatment-downtime-after-laser-therapy-in-scar-repair-/18625/E. Victor Ross, MD discusses how treatment downtime influences his approach for treating scars. His goal, he said, is to achieve the highest degree of efficacy possible with laser used as mono- or combination therapy while being mindful of patients' comfort levels with the associated recovery periodHilary Baldwin, MD: Perspective on the FDA Citizen's Petition for Acne Products with Benzoyl Peroxide (BPO)
https://practicaldermatology.com/topics/acne-rosacea/hilary-baldwin-md-perspective-fda-citizens-petition-acne-products-benzoyl-peroxide-bpo/24171/Neal Bhatia, MD, chief medical editor of Practical Dermatology® talks to Hilary E. Baldwin, MD about a new report from an independent laboratory that finds benzene can form at unacceptably high levels in both over-the-counter and prescription medications that contain benzoyl peroxide.COVID-19 Impact: Navigating Clinical Research
https://practicaldermatology.com/series/dermatology-dispatches/covid-19-impact-navigating-clinical-research/19771/Conducting clinical research studies is challenging as the majority of Americans are under stay-at-home orders for the forseeable future due to the COVID-19 pandemic, says Todd E. Schlesinger, MD. He suggests trialists do their best to say in contact with clinical research organizations, sponsors, aPatient Surveys: When and Why
https://practicaldermatology.com/topics/practice-management/patient-surveys-when-and-why/19112/Todd E. Schlesinger, MD, discusses the benefits of patient surveys and offers tips to get the most out of surveys. Sometimes negative survey responses offer value to the practice--if you use the feedback to improve. Coverage from Vegas Cosmetic Surgery 2014.The Case for JAK Inhibitors to Treat AD
https://practicaldermatology.com/topics/atopic-dermatitis/case-jak-inhibitors-treat-ad/27109/E. James Song, MD, FAAD, Director of Clinical Research and Co-Chief Medical Officer for Frontier Dermatology, discusses his presentation “JAK Inhibitors in Atopic Dermatitis” from the 2024 American Academy of Dermatology (AAD) Innovation Academy.